Listed

BWX Technologies, Inc.: Form 10-Q for the period ended Jun 30, 2020

Filed with the SEC on Aug 3, 2020 and accepted by EDGAR at Aug 3, 2020, 16:41 ET.

Share

Management's discussion and analysis

As filed, 46,939 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS

The following information should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included under Item 1 of this quarterly report on Form 10-Q ("Report") and the audited consolidated financial statements and the related notes and Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in our annual report on Form 10-K for the year ended December 31, 2019 (our "2019 10-K").

In this Report, unless the context otherwise indicates, "we," "us" and "our" mean BWX Technologies, Inc. ("BWXT" or the "Company") and its consolidated subsidiaries.

From time to time, our management or persons acting on our behalf make forward-looking statements to inform existing and potential security holders about our Company. Forward-looking statements include those statements that express a belief, expectation or intention, as well as those that are not statements of historical fact, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Statements and assumptions regarding expectations and projections of specific projects, our future backlog, revenues, income and capital spending, strategic investments, acquisitions or divestitures, return of capital activities, margin improvement initiatives or impacts of the novel strain of coronavirus ("COVID-19") pandemic are examples of forward-looking statements. Forward-looking statements are generally accompanied by words such as "estimate," "project," "predict," "believe," "expect," "anticipate," "plan," "seek," "goal," "could," "intend," "may," "should" or other words that convey the uncertainty of future events or outcomes. In addition, sometimes we will specifically describe a statement as being a forward-looking statement and refer to this cautionary statement.

We have based our forward-looking statements on information currently available to us and our current expectations, estimates and projections about our industries and our Company. We caution that these statements are not guarantees of future performance and you should not rely unduly on them as they involve risks, uncertainties and assumptions that we cannot predict. In addition, we have based many of these forward-looking statements on assumptions about future events that may prove to be inaccurate. For example, the extent to which the COVID-19 outbreak impacts our business will depend on future developments that are highly uncertain and cannot be predicted, including new information that may emerge concerning the length and severity of the COVID-19 health crisis, and the actions to contain its impact, in addition to the potential recurrence or subsequent waves of COVID-19 or similar diseases. While our management considers these statements and assumptions to be reasonable, they are inherently subject to numerous factors, including potentially the risk factors described in the sections labeled Item 1A, "Risk Factors" of our 2019 10-K, of our quarterly report on Form 10-Q for the quarter ended March, 31, 2020 (our "First Quarter 2020 10-Q") and of this Report, most of which are difficult to predict and many of which are beyond our control. Accordingly, our actual results may differ materially from the future performance that we have expressed or forecast in our forward-looking statements.

We have discussed many of these factors in more detail elsewhere in this Report, including under the heading "COVID-19 Assessment" of this Item 2 "Management's Discussion and Analysis of Financial Condition and Results of Operations" and Item 1A, "Risk Factors", and in Item 1A "Risk Factors" in our 2019 10-K and our First Quarter 2020 10-Q. These factors are not necessarily all the factors that could affect us. Unpredictable or unanticipated factors we have not discussed in this Report or in our 2019 10-K and our First Quarter 2020 10-Q could also have material adverse effects on actual results of matters that are the subject of our forward-looking statements. We do not intend to update or review any forward-looking statement or our description of important factors, whether as a result of new information, future events or otherwise, except as required by applicable laws.

GENERAL

We operate in three reportable segments: Nuclear Operations Group, Nuclear Power Group and Nuclear Services Group. In general, we operate in capital-intensive industries and rely on large contracts for a substantial amount of our revenues. We are currently exploring growth strategies across our segments to expand and complement our existing businesses. We would expect to fund these opportunities with cash generated from operations or by raising additional capital through debt, equity or some combination thereof.

Nuclear Operations Group

The revenues of our Nuclear Operations Group segment are largely a function of defense spending by the U.S. Government. Through this segment, we engineer, design and manufacture precision naval nuclear components, reactors and nuclear fuel for the DOE/NNSA's Naval Nuclear Propulsion Program. In addition, we perform development and fabrication activities for missile launch tubes for U.S. Navy submarines. As a supplier of major nuclear components for certain U.S. Government programs, this segment is a significant participant in the defense industry.

Nuclear Power Group

Through this segment, we design and manufacture commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, as well as other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. This segment is a leading supplier of nuclear fuel, fuel handling systems, tooling delivery systems, nuclear-grade materials and precisely machined components, and related services for CANDU nuclear power plants. This segment also provides a variety of engineering and in-plant services and is a significant supplier to nuclear power utilities undergoing major refurbishment and plant life extension projects. Additionally, this segment is a leading global manufacturer and supplier of critical medical radioisotopes and radiopharmaceuticals.

Our Nuclear Power Group segment's overall activity primarily depends on the demand and competitiveness of nuclear energy. A significant portion of our Nuclear Power Group segment's operations depend on the timing of maintenance and refueling outages, the cyclical nature of capital expenditures and major refurbishment and life extension projects, as well as the demand for nuclear fuel and fuel handling equipment primarily in the Canadian market, which could cause variability in our financial results.

Nuclear Services Group

Our Nuclear Services Group segment provides various services to the U.S. Government. The revenues and equity in income of investees under our U.S. Government contracts are largely a function of spending of the U.S. Government and the performance scores we and our consortium partners earn in managing and operating high-consequence operations at U.S. nuclear weapons sites, national laboratories and manufacturing complexes. With its specialized capabilities of full life-cycle management of special materials, facilities and technologies, we believe our Nuclear Services Group segment is well-positioned to continue to participate in the continuing cleanup, operation and management of critical government-owned nuclear sites, laboratories and manufacturing complexes maintained by the DOE, NASA and other federal agencies. This segment also develops technology for a variety of applications, including advanced nuclear power sources, and offers complete advanced nuclear fuel and reactor design and engineering, licensing and manufacturing services for new advanced nuclear reactors.

Divestiture of U.S.-Based Commercial Nuclear Services Business

On May 29, 2020, our subsidiary BWXT Nuclear Energy, Inc. divested its U.S.-based commercial nuclear services business, a component of our Nuclear Services Group segment. In a cashless transaction, we exchanged net assets totaling $18.0 million, consisting primarily of property, plant and equipment and certain warranty obligations, for a manufacturing facility and the associated land of approximately the same value. The acquired assets are reported as part of the Nuclear Services Group segment.

Acquisition of Laker Energy Products Ltd.

On January 2, 2020, our subsidiary BWXT Canada Ltd. acquired Laker Energy Products Ltd. ("Laker Energy Products"). Laker Energy Products is a global supplier of nuclear-grade materials and precisely machined components for CANDU nuclear power utilities and employs approximately 140 personnel. Laker Energy Products is reported as part of our Nuclear Power Group segment.

Critical Accounting Policies and Estimates

For a summary of the critical accounting policies and estimates that we use in the preparation of our unaudited condensed consolidated financial statements, see Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2019 10-K. There have been no material changes to our critical accounting policies during the six months ended June 30, 2020 with the exception of the adoption of Financial Accounting Standards Board ("FASB") Topic Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment as described in the notes to the condensed consolidated financial statements in Part I of this Report.

Accounting for Contracts

On certain of our performance obligations, we recognize revenue over time. In accordance with FASB Topic Revenue from Contracts with Customers, we are required to estimate the total amount of costs on these performance obligations. As of June 30, 2020, we have provided for the estimated costs to complete all of our ongoing contracts. However, it is possible that current estimates could change due to unforeseen events, which could result in adjustments to overall contract revenues and costs. A principal risk on fixed-price contracts is that revenue from the customer is insufficient to cover increases in our costs. It is possible that current estimates could materially change for various reasons, including, but not limited to, fluctuations in forecasted labor productivity or steel and other raw material prices. In some instances, we guarantee completion dates related to our projects or provide performance guarantees. Increases in costs on our fixed-price contracts could have a material adverse impact on our consolidated results of operations, financial condition and cash flows. Alternatively, reductions in overall contract costs at completion could materially improve our consolidated results of operations, financial condition and cash flows. During the three months ended June 30, 2020 and 2019, we recognized net changes in estimates related to contracts that recognize revenue over time, which increased operating income by approximately $11.4 million and $18.9 million, respectively. During the six months ended June 30, 2020 and 2019, we recognized net changes in estimates related to contracts that recognize revenue over time, which increased operating income by approximately $21.0 million and $23.7 million, respectively.

COVID-19 Assessment

A global outbreak of COVID-19 has occurred impacting over 200 countries, including the U.S. and Canada where we maintain our principal operations. Developments have been occurring rapidly with respect to the spread of COVID-19 and its impact on human health and businesses, with new and changing government actions occurring on a daily basis. As a result, we have been closely monitoring the COVID-19 pandemic and its impacts and potential impacts on our business.

We have received notifications from the U.S. and Canadian governments designating BWXT as an essential business given our roles in national security, energy production and medical manufacturing. We continue to operate our facilities and have taken numerous precautions to mitigate exposure and protect the health and well-being of our workforce. The COVID-19 pandemic has not caused a significant disruption to our operations or our supply chain to date.

Because developments related to the spread of COVID-19 and its impacts have been occurring rapidly, it is difficult to predict any future impact at this time. We may experience material disruptions to demand for our products and services and our operations in the future as a result of, among other things, national, state, provincial or local government enforced quarantines, worker illness or absenteeism, and travel and other restrictions. For example, we have experienced a year over year decline in revenues in our medical radioisotopes and radiopharmaceuticals business due to a decrease in demand for elective diagnostic procedures. For similar reasons, the COVID-19 pandemic may also adversely impact our supply chain and other manufacturers which could delay our receipt of essential goods and services. For example, certain services scheduled during nuclear power plant outages during which our Nuclear Power Group segment would operate have been rescheduled. We have also experienced delays in the bidding and contracting process for our U.S. Government businesses due to COVID-19 concerns. Any number of these potential risks could have a material adverse effect on our financial condition, results of operations and cash flows. The extent to which the COVID-19 outbreak impacts our business will depend on future developments that are highly uncertain and cannot be predicted, including new information that may emerge concerning the severity of the virus and the actions to contain its impact.

See Item 1A "Risk Factors" in this Report for an additional discussion of risks of the COVID-19 pandemic on our business.

RESULTS OF OPERATIONS – THREE AND SIX MONTHS ENDED JUNE 30, 2020 VS. THREE AND SIX MONTHS ENDED JUNE 30, 2019

Selected financial highlights are presented in the table below:

(In thousands)

REVENUES: Three Months Ended June 30, 2020 2019 $ Change Six Months Ended June 30, 2020 2019 $ Change
Nuclear Operations Group $410,252 $358,352 $51,900 $834,027 $663,153 $170,874
Nuclear Power Group 67,983 86,639 (18,656) 155,900 171,038 (15,138)
Nuclear Services Group 33,328 29,829 3,499 70,093 58,923 11,170
Eliminations (7,043) (3,589) (3,454) (13,292) (5,429) (7,863)
$504,520 $471,231 $33,289 $1,046,728 $887,685 $159,043
OPERATING INCOME:
Nuclear Operations Group $85,972 $75,226 $10,746 $176,331 $132,851 $43,480
Nuclear Power Group 1,102 14,883 (13,781) 9,572 27,466 (17,894)
Nuclear Services Group 4,122 1,490 2,632 10,522 3,061 7,461
Other (5,600) (6,744) 1,144 (10,959) (12,840) 1,881
$85,596 $84,855 $741 $185,466 $150,538 $34,928
Unallocated Corporate (3,162) (4,320) 1,158 (4,765) (6,359) 1,594
Total Operating Income $82,434 $80,535 $1,899 $180,701 $144,179 $36,522

Consolidated Results of Operations

Three months ended June 30, 2020 vs. 2019

Consolidated revenues increased 7.1%, or $33.3 million, to $504.5 million in the three months ended June 30, 2020 compared to $471.2 million for the corresponding period in 2019, due to increases in revenues from our Nuclear Operations Group and Nuclear Services Group segments totaling $51.9 million and $3.5 million, respectively. These increases were partially offset by a decrease in revenues in our Nuclear Power Group segment of $18.7 million.

Consolidated operating income increased $1.9 million to $82.4 million in the three months ended June 30, 2020 compared to $80.5 million for the corresponding period of 2019. Operating income in our Nuclear Operations Group, Nuclear Services Group and Other segments increased by $10.7 million, $2.6 million, and $1.1 million, respectively. In addition, we experienced lower Unallocated Corporate expenses of $1.2 million when compared to the corresponding period of 2019. These increases were partially offset by a decrease in operating income in our Nuclear Power Group segment of $13.8 million.

Six months ended June 30, 2020 vs. 2019

Consolidated revenues increased 17.9%, or $159.0 million, to $1,046.7 million in the six months ended June 30, 2020 compared to $887.7 million for the corresponding period in 2019, due to increases in revenues from our Nuclear Operations Group and Nuclear Services Group segments totaling $170.9 million and $11.2 million, respectively. These increases were partially offset by a decrease in revenues in our Nuclear Power Group segment of $15.1 million.

Consolidated operating income increased $36.5 million to $180.7 million in the six months ended June 30, 2020 compared to $144.2 million for the corresponding period of 2019. Operating income in our Nuclear Operations Group, Nuclear Services Group and Other segments increased by $43.5 million, $7.5 million, and $1.9 million, respectively. In addition, we experienced lower Unallocated Corporate expenses of $1.6 million when compared to the corresponding period of 2019. These increases were partially offset by a decrease in operating income in our Nuclear Power Group segment of $17.9 million.

Nuclear Operations Group

(In thousands)

Three Months Ended June 30, 2020 2019 $ Change Six Months Ended June 30, 2020 2019 $ Change
Revenues $410,252 $358,352 $51,900 $834,027 $663,153 $170,874
Operating Income $85,972 $75,226 $10,746 $176,331 $132,851 $43,480
% of Revenues 21.0% 21.0% 21.1% 20.0%

Three months ended June 30, 2020 vs. 2019

Revenues increased 14.5%, or $51.9 million, to $410.3 million in the three months ended June 30, 2020 compared to $358.4 million for the corresponding period of 2019. The increase related to the timing of the procurement of certain long-lead materials when compared to the corresponding period of 2019 as well as additional volume in our naval nuclear fuel and downblending operations.

Operating income increased $10.7 million to $86.0 million in the three months ended June 30, 2020 compared to $75.2 million for the corresponding period of 2019. The increase was due to the operating income impact of the changes in revenues noted above.

Six months ended June 30, 2020 vs. 2019

Revenues increased 25.8%, or $170.9 million, to $834.0 million in the six months ended June 30, 2020 compared to $663.2 million for the corresponding period of 2019 as we continue to expand production related to the Columbia-Class nuclear propulsion system. The increase comprised additional volume in the manufacture of nuclear components for U.S. Government programs and the timing of the procurement of certain long-lead materials when compared to the corresponding period of 2019.

Operating income increased $43.5 million to $176.3 million in the six months ended June 30, 2020 compared to $132.9 million for the corresponding period of 2019. The increase was due to the operating income impact of the changes in revenues noted above as well as favorable contract adjustments related to our naval nuclear fuel operations.

Nuclear Power Group

(In thousands)

Three Months Ended June 30, 2020 2019 $ Change Six Months Ended June 30, 2020 2019 $ Change
Revenues $67,983 $86,639 $(18,656) $155,900 $171,038 $(15,138)
Operating Income $1,102 $14,883 $(13,781) $9,572 $27,466 $(17,894)
% of Revenues 1.6% 17.2% 6.1% 16.1%

Three months ended June 30, 2020 vs. 2019

Revenues decreased 21.5%, or $18.7 million, to $68.0 million in the three months ended June 30, 2020 compared to $86.6 million for the corresponding period of 2019. The decrease was primarily related to lower revenues in our nuclear components business of $20.9 million largely attributable to decreased activity associated with major steam generator design and supply contracts as well as a decrease in volume associated with our medical radioisotopes business. These decreases were partially offset by revenues associated with the Laker Energy Products acquisition of $5.7 million.

Operating income decreased $13.8 million to $1.1 million in the three months ended June 30, 2020 compared to $14.9 million for the corresponding period of 2019, primarily attributable to the decrease in revenues noted above as well as a decline in operating margins as a result of net favorable changes in estimates related to certain long-term contracts recorded in the prior year.

Six months ended June 30, 2020 vs. 2019

Revenues decreased 8.9%, or $15.1 million, to $155.9 million in the six months ended June 30, 2020 compared to $171.0 million for the corresponding period of 2019. The decrease was primarily related to lower revenues in our nuclear components business of $11.3 million largely attributable to decreased activity associated with major steam generator design and supply contracts. We also experienced a decrease in revenue of $9.5 million due to lower levels of in-plant inspection, maintenance and modification services when compared to the same period in the prior year. These decreases were partially offset by revenues associated with the Laker Energy Products acquisition.

Operating income decreased $17.9 million to $9.6 million in the six months ended June 30, 2020 compared to $27.5 million for the corresponding period of 2019, primarily attributable to the decrease in revenues noted above as well as a decline in operating margins as a result of net favorable changes in estimates related to certain long-term contracts recorded in the prior year, as well a shift in our product line mix when compared to the same period in the prior year.

Nuclear Services Group

(In thousands)

Three Months Ended June 30, 2020 2019 $ Change Six Months Ended June 30, 2020 2019 $ Change
Revenues $33,328 $29,829 $3,499 $70,093 $58,923 $11,170
Operating Income $4,122 $1,490 $2,632 $10,522 $3,061 $7,461
% of Revenues 12.4% 5.0% 15.0% 5.2%

Three months ended June 30, 2020 vs. 2019

Revenues increased 11.7%, or $3.5 million, to $33.3 million in the three months ended June 30, 2020 compared to $29.8 million for the corresponding period of 2019, primarily attributable to an increase in design and engineering work executed by our advanced technologies business.

Operating income increased $2.6 million to $4.1 million in the three months ended June 30, 2020 compared to $1.5 million for the corresponding period of 2019. The increase was due to the operating income impact of the changes in revenues noted above in addition to a decrease in selling, general and administrative expenses related to business development activities caused by the timing of proposal activities.

Six months ended June 30, 2020 vs. 2019

Revenues increased 19.0%, or $11.2 million, to $70.1 million in the six months ended June 30, 2020 compared to $58.9 million for the corresponding period of 2019. The increase was primarily attributable to design and engineering work executed by our advanced technologies business and an increase in the volume of commercial nuclear inspection and maintenance outage work in the U.S. when compared to the same period in the prior year.

Operating income increased $7.5 million to $10.5 million in the six months ended June 30, 2020 compared to $3.1 million for the corresponding period of 2019 due to the operating income impact of the changes in revenues noted above.

Other

(In thousands)

Three Months Ended June 30, 2020 2019 $ Change Six Months Ended June 30, 2020 2019 $ Change
Operating Income $(5,600) $(6,744) $1,144 $(10,959) $(12,840) $1,881

Operating income increased $1.1 million and $1.9 million in the three and six months ended June 30, 2020, respectively, primarily due to a decrease in research and development activities related to our medical and industrial radioisotope capabilities and other advanced technologies when compared to the corresponding periods of the prior year.

Unallocated Corporate

Unallocated corporate expenses decreased $1.2 million and $1.6 million in the three and six months ended June 30, 2020, respectively, primarily due to a decrease in healthcare claims, which was partially offset by an increase in legal and consulting costs associated with the divestiture of our U.S.-based commercial nuclear services business during the second quarter of 2020.

Provision for Income Taxes

(In thousands)

Three Months Ended June 30, 2020 2019 $ Change Six Months Ended June 30, 2020 2019 $ Change
Income before Provision for Income Taxes $84,080 $77,734 $6,346 $182,528 $140,611 $41,917
Provision for Income Taxes $19,684 $18,734 $950 $42,512 $32,501 $10,011
Effective Tax Rate 23.4% 24.1% 23.3% 23.1%

We primarily operate in the U.S. and Canada, and we recognize our U.S. income tax provision based on the U.S. federal statutory rate of 21% and our Canadian tax provision based on the Canadian local statutory rate of approximately 25%.

Our effective tax rate for the three months ended June 30, 2020 was 23.4% as compared to 24.1% for the three months ended June 30, 2019. Our effective tax rate for the six months ended June 30, 2020 was 23.3% as compared to 23.1% for the six months ended June 30, 2019. The effective tax rates for the three and six months ended June 30, 2020 and 2019 were higher than the U.S. corporate income tax rate of 21% primarily due to state income taxes within the U.S. and the unfavorable rate differential associated with our Canadian earnings. Our effective tax rates for the six months ended June 30, 2020 and 2019 were favorably impacted by benefits recognized for excess tax benefits related to employee share-based payments of $0.9 million and $1.8 million, respectively.

Backlog

Backlog represents the dollar amount of revenue we expect to recognize in the future from contracts awarded and in progress. Not all of our expected revenue from a contract award is recorded in backlog for a variety of reasons, including that some projects are awarded and completed within the same reporting period.

Our backlog is equal to our remaining performance obligations under contracts that meet the criteria in FASB Topic Revenue from Contracts with Customers, as discussed in Note 3 to our condensed consolidated financial statements included in this Report. It is possible that our methodology for determining backlog may not be comparable to methods used by other companies.

We are subject to the budgetary and appropriations cycle of the U.S. Government as it relates to our Nuclear Operations Group and Nuclear Services Group segments. Backlog may not be indicative of future operating results, and projects in our backlog may be cancelled, modified or otherwise altered by customers.

June 30, 2020 (In approximate millions) December 31, 2019
Nuclear Operations Group $3,914 $4,515
Nuclear Power Group 771 730
Nuclear Services Group 43 43
Total Backlog $4,728 $5,288

We do not include the value of our unconsolidated joint venture contracts in backlog. These unconsolidated joint ventures are included in our Nuclear Services Group segment.

Of the backlog at June 30, 2020, we expect to recognize revenues as follows:

2020 (In approximate millions) 2021 Thereafter Total
Nuclear Operations Group $722 $1,098 $2,094 $3,914
Nuclear Power Group 178 209 384 771
Nuclear Services Group 33 5 5 43
Total Backlog $933 $1,312 $2,483 $4,728

At June 30, 2020, our Nuclear Operations Group segment's backlog with the U.S. Government was $3,516.4 million, $401.8 million of which had not yet been funded.

At June 30, 2020, our Nuclear Power Group segment had no backlog with the U.S. Government.

At June 30, 2020, our Nuclear Services Group segment's backlog with the U.S. Government was $37.7 million, all of which was funded.

Major new awards from the U.S. Government are typically received following Congressional approval of the budget for the U.S. Government's next fiscal year, which starts October 1, and may not be awarded to us before the end of the calendar year. Due to the fact that most contracts awarded by the U.S. Government are subject to these annual funding approvals, the total values of the underlying programs are significantly larger. In 2019, we received awards from the U.S. Government with a combined value in excess of $3.9 billion, inclusive of unexercised options, approximately $2.9 billion of which had been added to backlog as of June 30, 2020. The value of unexercised options excluded from backlog as of June 30, 2020 was approximately $1.0 billion, which is expected to be exercised through 2025, subject to annual Congressional appropriations.

Liquidity and Capital Resources

On June 12, 2020, we issued $400 million aggregate principal amount of our 4.125% senior notes due 2028 (the "Senior Notes due 2028") pursuant to an indenture dated June 12, 2020 (the "2020 Indenture") among the Company, the guarantors party thereto and U.S. Bank National Association, as trustee. The proceeds from the issuance of the Senior Notes due 2028 were used to (1) repay in full the Term Loans, as defined below, under our Credit Agreement dated May 24, 2018 (as amended, the "Credit Facility"), (2) repay a portion of the borrowings under the Revolving Credit Facility, as defined below, under the Credit Facility, and (3) pay all fees and expenses related to the issuance of the Senior Notes due 2028.

Credit Facility

On March 24, 2020, we entered into an Amendment No. 1 to Credit Agreement (the "Amendment"), which amended the Credit Facility with Wells Fargo Bank, N.A., as administrative agent, and the other lenders party thereto. The Credit Facility originally provided for a $500 million senior secured revolving credit facility (the "Revolving Credit Facility"), a $50 million U.S. dollar senior secured term loan A made available to the Company (the "USD Term Loan") and a $250 million (U.S. dollar equivalent) Canadian dollar senior secured term loan A made available to BWXT Canada Ltd. (the "CAD Term Loan" and together with the USD Term Loan, the "Term Loans"). On June 12, 2020, we repaid in full the Term Loans, at par, with a portion of the proceeds from the issuance of the Senior Notes due 2028.

The Amendment, among other things, (1) provided additional commitments to increase the Revolving Credit Facility by $250 million, such that the Revolving Credit Facility is now $750 million; (2) extended the maturity date of the Revolving Credit Facility to March 24, 2025; (3) removed BWXT Canada Ltd. as a borrower under the Revolving Credit Facility; (4) modified the applicable margin for borrowings under the Revolving Credit Facility to be, at the Company's option, either (i) the Eurocurrency rate plus a margin ranging from 1.0% to 1.75% per year or (ii) the base rate plus a margin ranging from 0.0% to 0.75% per year, in each case depending on the Company's leverage ratio; (5) modified the commitment fee on the unused portion of the Revolving Credit Facility to range from 0.15% to 0.225% per year, depending on the Company's leverage ratio; and (6) modified the letter of credit fee with respect to each financial letter of credit and performance letter of credit issued under the Revolving Credit Facility to range from 1.0% to 1.75% and 0.75% to 1.05% per year, respectively, in each case, depending on the Company's leverage ratio.

All obligations under the Revolving Credit Facility are scheduled to mature on March 24, 2025. The proceeds of loans under the Revolving Credit Facility are available for working capital needs, permitted acquisitions and other general corporate purposes.

The Credit Facility allows for additional parties to become lenders and, subject to certain conditions, for the increase of the commitments under the Credit Facility, subject to an aggregate maximum for all additional commitments of (1) the greater of (a) $250 million and (b) 65% of EBITDA, as defined in the Credit Facility, for the last four full fiscal quarters, plus (2) all voluntary prepayments of the Term Loans, plus (3) additional amounts provided the Company is in compliance with a pro forma first lien leverage ratio test of less than or equal to 2.50 to 1.00.

The Company's obligations under the Credit Facility are guaranteed, subject to certain exceptions, by substantially all of the Company's present and future wholly owned domestic restricted subsidiaries. The Credit Facility is secured by first-priority liens on certain assets owned by the Company and its subsidiary guarantors (other than its subsidiaries comprising its Nuclear Operations Group segment and a portion of its Nuclear Services Group segment).

The Revolving Credit Facility requires interest payments on revolving loans on a periodic basis until maturity. We may prepay all loans under the Credit Facility at any time without premium or penalty (other than customary Eurocurrency breakage costs), subject to notice requirements.

The Credit Facility includes financial covenants that are tested on a quarterly basis, based on the rolling four-quarter period that ends on the last day of each fiscal quarter. The maximum permitted leverage ratio is 4.00 to 1.00, which may be increased to 4.50 to 1.00 for up to four consecutive fiscal quarters after a material acquisition. The minimum consolidated interest coverage ratio is 3.00 to 1.00. In addition, the Credit Facility contains various restrictive covenants, including with respect to debt, liens, investments, mergers, acquisitions, dividends, equity repurchases and asset sales. As of June 30, 2020, we were in compliance with all covenants set forth in the Credit Facility.

Outstanding loans under the Revolving Credit Facility bear interest at our option at either (1) the Eurocurrency rate plus a margin ranging from 1.0% to 1.75% per year or (2) the base rate plus a margin ranging from 0.0% to 0.75% per year. We are charged a commitment fee on the unused portion of the Revolving Credit Facility, and that fee ranges from 0.15% to 0.225% per year. Additionally, we are charged a letter of credit fee of between 1.0% and 1.75% per year with respect to the amount of each financial letter of credit issued under the Credit Facility, and a letter of credit fee of between 0.75% and 1.05% per year with respect to the amount of each performance letter of credit issued under the Credit Facility. The applicable margin for loans, the commitment fee and the letter of credit fees set forth above will vary quarterly based on our leverage ratio. Based on the leverage ratio applicable at June 30, 2020, the margin for Eurocurrency rate and base rate revolving loans was 1.25% and 0.25%, respectively, the letter of credit fee for financial letters of credit and performance letters of credit was 1.25% and 0.825%, respectively, and the commitment fee for the unused portion of the Revolving Credit Facility was 0.175%.

As of June 30, 2020, borrowings and letters of credit issued under the Revolving Credit Facility totaled $40.0 million and $64.7 million, respectively. As a result, as of June 30, 2020 we had $645.3 million available under the Revolving Credit Facility for borrowings and to meet letter of credit requirements. As of June 30, 2020, the interest rate on outstanding borrowings under our Credit Facility was 1.43%.

The Credit Facility generally includes customary events of default for a secured credit facility. Under the Credit Facility, (1) if an event of default relating to bankruptcy or other insolvency events occurs with respect to the Company, all related obligations will immediately become due and payable; (2) if any other event of default exists, the lenders will be permitted to accelerate the maturity of the related obligations outstanding; and (3) if any event of default exists, the lenders will be permitted to terminate their commitments thereunder and exercise other rights and remedies, including the commencement of foreclosure or other actions against the collateral.

If any default occurs under the Credit Facility, or if we are unable to make any of the representations and warranties in the Credit Facility, we will be unable to borrow funds or have letters of credit issued under the Credit Facility.

Senior Notes due 2026

We issued $400 million aggregate principal amount of 5.375% senior notes due 2026 (the "Senior Notes due 2026") pursuant to an indenture dated May 24, 2018 (the "2018 Indenture"), among the Company, certain of our subsidiaries, as guarantors, and U.S. Bank National Association, as trustee. The Senior Notes due 2026 are guaranteed by each of the Company's present and future direct and indirect wholly owned domestic subsidiaries that is a guarantor under the Credit Facility.

Interest on the Senior Notes due 2026 is payable semi-annually in cash in arrears on January 15 and July 15 of each year, which commenced on July 15, 2018, at a rate of 5.375% per annum. The Senior Notes due 2026 will mature on July 15, 2026.

On and after July 15, 2021, the Company may redeem the Senior Notes due 2026, in whole or in part, at a redemption price equal to (i) 102.688% of the principal amount to be redeemed if the redemption occurs during the twelve-month period beginning on July 15, 2021, (ii) 101.344% of the principal amount to be redeemed if the redemption occurs during the twelve-month period beginning on July 15, 2022 and (iii) 100.0% of the principal amount to be redeemed if the redemption occurs on or after July 15, 2023, in each case plus accrued and unpaid interest, if any, to, but excluding, the redemption date. At any time prior to July 15, 2021, the Company may also redeem up to 40.0% of the Senior Notes due 2026 with net cash proceeds of certain equity offerings at a redemption price equal to 105.375% of the principal amount of the Senior Notes due 2026 to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. In addition, at any time prior to July 15, 2021, the Company may redeem the Senior Notes due 2026, in whole or in part, at a redemption price equal to 100.0% of the principal amount of the Senior Notes due 2026 to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date plus an applicable "make-whole" premium.

The 2018 Indenture contains customary events of default, including, among other things, payment default, failure to comply with covenants or agreements contained in the 2018 Indenture or the Senior Notes due 2026 and certain provisions related to bankruptcy events. The 2018 Indenture also contains customary negative covenants. As of June 30, 2020, we were in compliance with all covenants set forth in the 2018 Indenture and the Senior Notes due 2026.

Senior Notes due 2028

We issued $400 million aggregate principal amount of our Senior Notes due 2028 pursuant to the 2020 Indenture. The Senior Notes due 2028 are guaranteed by each of the Company's present and future direct and indirect wholly owned domestic subsidiaries that is a guarantor under the Credit Facility.

Interest on the Senior Notes due 2028 is payable semi-annually in cash in arrears on June 30 and December 30 of each year, commencing on December 30, 2020, at a rate of 4.125% per annum. The Senior Notes due 2028 will mature on June 30, 2028.

The Company may redeem the Senior Notes due 2028, in whole or in part, at any time on or after June 30, 2023 at a redemption price equal to (i) 102.063% of the principal amount to be redeemed if the redemption occurs during the twelve-month period beginning on June 30, 2023, (ii) 101.031% of the principal amount to be redeemed if the redemption occurs during the twelve-month period beginning on June 30, 2024 and (iii) 100.0% of the principal amount to be redeemed if the redemption occurs on or after June 30, 2025, in each case plus accrued and unpaid interest, if any, to, but excluding, the redemption date. At any time prior to June 30, 2023, the Company may also redeem up to 40.0% of the Senior Notes due 2028 with net cash proceeds of certain equity offerings at a redemption price equal to 104.125% of the principal amount of the Senior Notes due 2028 to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. In addition, at any time prior to June 30, 2023, the Company may redeem the Senior Notes due 2028, in whole or in part, at a redemption price equal to 100.0% of the principal amount of the Senior Notes due 2028 to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date plus an applicable "make-whole" premium.

The 2020 Indenture contains customary events of default, including, among other things, payment default, failure to comply with covenants or agreements contained in the 2020 Indenture or the Senior Notes due 2028 and certain provisions related to bankruptcy events. The 2020 Indenture also contains customary negative covenants. As of June 30, 2020, we were in compliance with all covenants set forth in the 2020 Indenture and the Senior Notes due 2028.

Other Arrangements

We have posted surety bonds to support regulatory and contractual obligations for certain decommissioning responsibilities, projects and legal matters. We utilize bonding facilities to support such obligations, but the issuance of bonds under those facilities is typically at the surety's discretion, and the bonding facilities generally permit the surety, in its sole discretion, to terminate the facility or demand collateral. Although there can be no assurance that we will maintain our surety bonding capacity, we believe our current capacity is adequate to support our existing requirements for the next twelve months. In addition, these bonds generally indemnify the beneficiaries should we fail to perform our obligations under the applicable agreements. We, and certain of our subsidiaries, have jointly executed general agreements of indemnity in favor of surety underwriters relating to surety bonds those underwriters issue. As of June 30, 2020, bonds issued and outstanding under these arrangements totaled approximately $73.3 million.

Long-term Benefit Obligations

As of June 30, 2020, we had underfunded defined benefit pension and postretirement benefit plans with obligations totaling approximately $183.2 million. These long-term liabilities are expected to require use of our resources to satisfy future funding obligations. Based largely on statutory funding requirements, we expect to make contributions of approximately $5.6 million for the remainder of 2020 related to our pension and postretirement plans. We may also make additional contributions based on a variety of factors including, but not limited to, tax planning, evaluation of funded status and risk mitigation strategies.

Other

Our domestic and foreign cash and cash equivalents, restricted cash and cash equivalents and investments as of June 30, 2020 and December 31, 2019 were as follows:

(In thousands)

June 30, 2020 December 31, 2019
Domestic $60,709 $76,337
Foreign 17,793 29,526
Total $78,502 $105,863

Our working capital increased by $23.6 million to $248.6 million at June 30, 2020 from $225.0 million at December 31, 2019, primarily attributable to changes in contracts in progress and advance billings due to the timing of project cash flows and a decrease in accounts payable associated with the timing of vendor payments, partially offset by an increase in income taxes payable.

Our net cash provided by operating activities increased by $108.6 million to $155.6 million in the six months ended June 30, 2020, compared to $47.1 million in the six months ended June 30, 2019. The increase in cash provided by operating activities was primarily attributable to an increase in net income and a decrease in working capital needs for the period ended June 30, 2020.

Our net cash used in investing activities increased by $53.7 million to $129.4 million in the six months ended June 30, 2020, compared to $75.7 million in the six months ended June 30, 2019. The increase in cash used in investing activities was primarily attributable to an increase in purchases of property, plant and equipment of $39.8 million as well as our acquisition of Laker Energy Products for $16.2 million in the three months ended March 31, 2020.

Our net cash used in financing activities increased by $83.6 million to $50.4 million in the six months ended June 30, 2020, compared to cash provided by financing activities of $33.3 million in the six months ended June 30, 2019. The increase in cash used in financing activities was primarily attributable to a decrease in net borrowings of $77.9 million and the payment of debt issuance costs of $6.3 million in the six months ended June 30, 2020.

At June 30, 2020, we had restricted cash and cash equivalents totaling $6.0 million, $2.9 million of which was held for future decommissioning of facilities (which is included in other assets on our condensed consolidated balance sheets) and $3.1 million of which was held to meet reinsurance reserve requirements of our captive insurer.

At June 30, 2020, we had short-term and long-term investments with a fair value of $10.9 million. Our investment portfolio consists primarily of U.S. Government and agency securities, corporate bonds and mutual funds. Our debt securities are carried at fair value and are either classified as trading, with unrealized gains and losses reported in earnings, or as available-for-sale, with unrealized gains and losses, net of tax, being reported as a component of other comprehensive income. Our equity securities are carried at fair value with the unrealized gains and losses reported in earnings.

Based on our liquidity position, we believe we have sufficient cash and letter of credit and borrowing capacity to fund our operating requirements for at least the next 12 months.

Market risk

As filed, 127 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our exposures to market risks have not changed materially from those disclosed in Item 7A included in Part II of our 2019 10-K.

Controls and procedures

As filed, 1,945 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

As of the end of the period covered by this Report, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as that term is defined in Rules 13a-15(e) and 15d-15(e) adopted by the Securities and Exchange Commission ("SEC") under the Exchange Act). This evaluation was conducted under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer. Our disclosure controls and procedures were developed through a process in which our management applied its judgment in assessing the costs and benefits of such controls and procedures, which, by their nature, can provide only reasonable assurance regarding the control objectives. You should note that the design of any system of disclosure controls and procedures is based in part upon various assumptions about the likelihood of future events, and we cannot assure you that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote. Based on the evaluation referred to above, our Chief Executive Officer and Chief Financial Officer concluded that the design and operation of our disclosure controls and procedures are effective as of June 30, 2020 to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and such information is accumulated and communicated to management as appropriate to allow timely decisions regarding disclosure. There has been no change in our internal control over financial reporting during the three months ended June 30, 2020 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II

OTHER INFORMATION

Risk factors

As filed, 3,869 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

In addition to the other information in this Report, the other factors presented in Item 1A "Risk Factors" in our 2019 10-K and our First Quarter Form 10-Q are some of the factors that could materially affect our business, financial condition or future results. There have been no material changes to our risk factors from those disclosed in our 2019 10-K or our First Quarter Form 10-Q, except as noted below:

Actual or threatened public health epidemics or outbreaks, such as the recent outbreak of the COVID-19 illness, could have a material adverse effect on our business and results of operations.

Actual or threatened public health epidemics or outbreaks, such as the recent global outbreak of the novel coronavirus disease ("COVID-19"), could have a material adverse effect on our business and results of operations. COVID-19, which has been declared by the World Health Organization to be a pandemic, has spread to over 200 countries, including every state in the United States. COVID-19 is impacting worldwide economic activity and has resulted in travel disruption, trade disruption and has affected companies’ operations around the world, including us. A public health epidemic, including COVID-19, poses the risk that we or our employees, contractors, suppliers, customers and other partners may be prevented from conducting business activities for an indefinite period of time, including due to shutdowns that may be requested or mandated by governmental authorities. If significant portions of our workforce are unable to work effectively, including because of illness, quarantines, government actions, facility closures or other restrictions in connection with the COVID-19 pandemic, our operations will likely be impacted. Although our U.S. and Canadian facilities have to date been deemed "essential" by federal, state and local authorities and currently continue to operate, there can be no assurance that such authorities will not impose restrictions on the operations of our facilities as a result of the COVID-19 pandemic or that our facilities will continue to operate during the pandemic. If our operations or the operations of our customers or our suppliers are restricted, we may be unable to perform fully on our contracts and our costs may increase as a result of the COVID-19 outbreak. These cost increases may result in unfavorable changes in estimates which may not be fully recoverable or adequately covered by insurance.

While it is not possible at this time to estimate the impact that COVID-19 could have on our business, the continued spread of COVID-19 and the measures taken by the governments of countries affected, as well as measures taken by state and local authorities in the United States, could disrupt the supply chain and the manufacture or shipment of our products and adversely impact our business, financial condition or results of operations. We have already experienced delays in the bidding and contracting process for our U.S. Government businesses, as well as the rescheduling of certain services that our Canadian nuclear service business provides during nuclear power plant outages. Additionally, we have noted a year over year decline in revenues in our medical radioisotopes and radiopharmaceuticals business due to a decrease in demand for elective diagnostic procedures. More widespread or further delays could have a material adverse impact on our results of operations.

The COVID-19 outbreak and mitigation measures may also have an adverse impact on global economic conditions, which could have an adverse effect on our business. The extent to which the COVID-19 outbreak impacts our business will depend on future developments that are highly uncertain and cannot be predicted, including new information that may emerge concerning the severity of the virus and the actions to contain its impact.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-04-01 to 2020-06-30$504.5mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2020-01-01 to 2020-06-30$1.05bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2020-04-01 to 2020-06-30$367.5mus-gaap:CostOfRevenue
Cost of revenue6 months2020-01-01 to 2020-06-30$760.0mus-gaap:CostOfRevenue
Research and development3 months2020-04-01 to 2020-06-30$4.0mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2020-01-01 to 2020-06-30$8.6mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2020-04-01 to 2020-06-30$55.1mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2020-01-01 to 2020-06-30$108.1mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2020-04-01 to 2020-06-30$82.4mus-gaap:OperatingIncomeLoss
Operating income6 months2020-01-01 to 2020-06-30$180.7mus-gaap:OperatingIncomeLoss
Interest expense3 months2020-04-01 to 2020-06-30$7.9mus-gaap:InterestExpense
Interest expense6 months2020-01-01 to 2020-06-30$15.8mus-gaap:InterestExpense
Income tax3 months2020-04-01 to 2020-06-30$19.7mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2020-01-01 to 2020-06-30$42.5mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2020-04-01 to 2020-06-30$64.3mus-gaap:NetIncomeLoss
Net income6 months2020-01-01 to 2020-06-30$139.8mus-gaap:NetIncomeLoss
Diluted EPS3 months2020-04-01 to 2020-06-30$0.67us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2020-01-01 to 2020-06-30$1.46us-gaap:EarningsPerShareDiluted
Basic EPS3 months2020-04-01 to 2020-06-30$0.67us-gaap:EarningsPerShareBasic
Basic EPS6 months2020-01-01 to 2020-06-30$1.46us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2020-04-01 to 2020-06-3095,633,571 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2020-01-01 to 2020-06-3095,694,972 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2020-01-01 to 2020-06-30$155.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2020-01-01 to 2020-06-30$115.5mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2020-01-01 to 2020-06-30$36.8mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases6 months2020-01-01 to 2020-06-30$20.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2020-06-30$61.6mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-06-30$624.0mus-gaap:AssetsCurrent
Total assetsAt period end2020-06-30$1.97bnus-gaap:Assets
Current liabilitiesAt period end2020-06-30$375.3mus-gaap:LiabilitiesCurrent
Long-term debtAt period end2020-06-30$826.8mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2020-06-30$481.5mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001486957-20-000041. Last ingested by Listed: Nov 14, 2026, 19:14 ET. Listed shows no prices and gives no investment advice.